The scale of managing the exploding universe of privileges requires an integrated, universal approach, rather than relying on a stack of niche tools, each only helping to manage a slice of the privilege problem. This is especially true when the elastic…
The ninth annual Microsoft Vulnerabilities Report returns to provide a digestible analysis of the current Microsoft vulnerabilities landscape — even after recent changes in vulnerability reporting. Two years ago, Microsoft announced changes to…
Many of the workplace changes accelerated by the pandemic are expected to endure, and a more durable hybrid work environment is taking root. The hybrid workplace has been called a "cybersecurity nightmare," and "a hacker’s dream". W…
When applying the granularity of privileged access management (PAM), including secure remote access, a zero trust approach ensures all access is appropriate, managed, and documented. Regardless of how the perimeter has been redefined. Download and r…
Download this checklist to learn about the four necessary capabilities of a true cybersecurity mesh platform: Broad, Integrated, Automated, Open Ecosystem.Request Free!
Download this eBook to learn why a structured approach to cybersecurity is the most effective strategy to address today’s sophisticated threat landscape.Request Free!
Developing healthcare regulated solutions in the cloud presents many challenges driven by the necessary security, privacy and regulatory controls. This involves a significant investment in resources, time and expertise that many&nbs…
Although we’ve heard about edge computing for a while, growth around new use cases continues. A recent study from the uptime institute shows that 58% of companies expect edge requirements to increase. However, with growing edge demand comes ne…
Artificial intelligence has tremendous potential to streamline Contract Management. Predictive Artificial Intelligence and Natural Language Processing can deliver significant benefits in next generation contract management and will uplevel the strategi…
These high-value drugs targeting complex or rare conditions are dominating today’s market, making up the majority of novel FDA drug approvals with new breakthroughs every year, along with a growing share of manufacturer revenue. The expanding …
